| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Zoe Bourgault, Justin Matheson, Robert E Mann, Bruna Brands, Christine M Wickens, Arun K Tiwari, Clement C Zai, James Kennedy, Bernard Le Fol. Mu opioid receptor gene variant modulates subjective response to smoked cannabis. American journal of translational research. vol 14. issue 1. 2022-02-17. PMID:35173880. |
functional interactions between the opioid and endocannabinoid systems are established and have been hypothesized to contribute to the effects of cannabis. |
2022-02-17 |
2023-08-13 |
Not clear |
| Jeffrey Landrigan, Kitti Bessenyei, Damian Leitner, Igor Yakovenko, John D Fisk, Jennifer L Prentic. A systematic review of the effects of cannabis on cognition in people with multiple sclerosis. Multiple sclerosis and related disorders. vol 57. 2022-02-15. PMID:35158449. |
the objective of this systematic review was to evaluate the effects of cannabis and medicinal cannabinoid products on cognition in pwms in order to provide guidance to clinicians and enable them to make evidence-based recommendations regarding cannabis and cannabinoid products. |
2022-02-15 |
2023-08-13 |
Not clear |
| Jonathan Tran, Aaron C Elkins, German C Spangenberg, Simone J Rochfor. High-Throughput Quantitation of Cannabinoids by Liquid Chromatography Triple-Quadrupole Mass Spectrometry. Molecules (Basel, Switzerland). vol 27. issue 3. 2022-02-15. PMID:35164007. |
the high-throughput quantitation of cannabinoids is important for the cannabis industry. |
2022-02-15 |
2023-08-13 |
Not clear |
| Hae-Won Son, Declan William Al. Endocannabinoid Receptor Expression in Early Zebrafish Development. Developmental neuroscience. 2022-02-15. PMID:35168237. |
the endocannabinoid system is widely studied due to its interactions with cannabis and its role in modulating physiological responses. |
2022-02-15 |
2023-08-13 |
human |
| Hae-Won Son, Declan William Al. Endocannabinoid Receptor Expression in Early Zebrafish Development. Developmental neuroscience. 2022-02-15. PMID:35168237. |
while most research has focused on the effects of cannabis on adult endocannabinoid systems, recent studies have begun to investigate the role of the endocannabinoid system in developing organisms. |
2022-02-15 |
2023-08-13 |
human |
| Rohan M Shah, Anjay Saklecha, Alpesh A Patel, Srikanth N Div. Analyzing the Impact of Cannabinoids on the Treatment of Spinal Disorders. Current reviews in musculoskeletal medicine. 2022-02-08. PMID:35132567. |
cannabinoids are a group of psychoactive substances found within the cannabis plant, with the most common being Δ |
2022-02-08 |
2023-08-13 |
Not clear |
| Colene Bentley, Sara Izadi-Najafabadi, Adam Raymakers, Helen McTaggart-Cowa. Qualitative Research Informing a Preference Study on Selecting Cannabis for Cancer Survivor Symptom Management: Design of a Discrete Choice Experiment. The patient. 2022-02-08. PMID:35132605. |
the legalization of recreational cannabis use can enable cancer survivors to manage aspects of their care with cannabinoids without medical authorization or stigmatization. |
2022-02-08 |
2023-08-13 |
Not clear |
| Małgorzata Śmiarowska, Monika Białecka, Anna Machoy-Mokrzyńsk. Cannabis and cannabinoids: pharmacology and therapeutic potential. Neurologia i neurochirurgia polska. 2022-02-08. PMID:35133644. |
cannabis and cannabinoids: pharmacology and therapeutic potential. |
2022-02-08 |
2023-08-13 |
Not clear |
| Meredith C Meacham, Alicia L Nobles, D Andrew Tompkins, Johannes Thru. "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PloS one. vol 17. issue 2. 2022-02-08. PMID:35134074. |
a growing body of research has reported on the potential opioid-sparing effects of cannabis and cannabinoids, but less is known about specific mechanisms. |
2022-02-08 |
2023-08-13 |
Not clear |
| Meredith C Meacham, Alicia L Nobles, D Andrew Tompkins, Johannes Thru. "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums. PloS one. vol 17. issue 2. 2022-02-08. PMID:35134074. |
future research is warranted with more structured assessments that examines the role of cannabis and cannabinoids in addressing both somatic and affective symptoms of opioid withdrawal. |
2022-02-08 |
2023-08-13 |
Not clear |
| Recardia Schoeman, Amy de la Harpe, Natasha Beukes, Carminita L Fros. Cannabis with breast cancer treatment: propitious or pernicious? 3 Biotech. vol 12. issue 2. 2022-02-07. PMID:35127309. |
cannabis is often used for its palliative effects in the form of purified cannabinoids, or as extracts. |
2022-02-07 |
2023-08-13 |
Not clear |
| Shiori Takashina, Miki Takahashi, Koji Morimoto, Koichi Inou. LC-MS/MS Assay for the Measurement of Cannabidiol Profiling in CBD Oil from Japanese Market and Application for Convertible Tetrahydrocannabinol in Acetic Acid Condition. Chemical & pharmaceutical bulletin. vol 70. issue 2. 2022-02-03. PMID:35110438. |
cannabidiol (cbd), a major non-psychoactive cannabinoid, has a lot of attention due to its potential relaxing properties and led the trend in commercial cbd aroma/oral hemp seed oil from the japanese market. |
2022-02-03 |
2023-08-13 |
Not clear |
| Shuangtao Li, Yuanbing Huang, Lijun Yu, Xiaoyu Ji, Jie W. Impact of the cannabinoid system in Alzheimer's diseases. Current neuropharmacology. 2022-02-02. PMID:35105293. |
cannabinoids are compounds that were initially isolated from cannabis marihuana and are also widely present in both nervous and immune systems of animals. |
2022-02-02 |
2023-08-13 |
human |
| Angela L Liang, Erin L Gingher, Jenell S Colema. Medical Cannabis for Gynecologic Pain Conditions: A Systematic Review. Obstetrics and gynecology. vol 139. issue 2. 2022-02-01. PMID:35104069. |
cannabis contains delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd), which are cannabinoids that bind to endocannabinoid system receptors. |
2022-02-01 |
2023-08-13 |
Not clear |
| Christopher A Legare, Wesley M Raup-Konsavage, Kent E Vran. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals. Pharmacology. 2022-01-30. PMID:35093949. |
while there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (cbd oil, cannabis extracts, and/or cannabis itself). |
2022-01-30 |
2023-08-13 |
Not clear |
| Valeria Lallai, Letizia Manca, Yasmine Sherafat, Christie D Fowle. Effects of Prenatal Nicotine, THC or Co-Exposure on Cognitive Behaviors in Adolescent Male and Female Rats. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2022-01-28. PMID:35090174. |
further, given the recent escalation in e-cigarette use and legalization of cannabis, it has become essential to understand the effects of nicotine and cannabinoid co-exposure during early developmental stages. |
2022-01-28 |
2023-08-13 |
rat |
| Lidya Kebede, Seyedehsara Masoomi Dezfooli, Ali Seyfoddi. Medicinal Cannabis Pharmacokinetics and Potential Methods of Delivery. Pharmaceutical development and technology. 2022-01-27. PMID:35084279. |
current cannabis products fail to address the undesirable characteristics associated with cannabinoids such as low solubility, poor bioavailability, and lack of specificity, all of which contribute to low therapeutic effect. |
2022-01-27 |
2023-08-13 |
Not clear |
| Stephanie E Reitsma, Hari Hara Sudhan Lakshmanan, Jennifer Johnson, Jiaqing Pang, Ivan Parra-Izquierdo, Alex R Melrose, Jaewoo Choi, Deirdre E J Anderson, Monica T Hinds, Jan Frederik Stevens, Joseph E Aslan, Owen J T McCarty, Jamie O L. Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in non-human primates reduces systemic platelet activity and function. American journal of physiology. Cell physiology. 2022-01-26. PMID:35080922. |
medical cannabis is administered for treatment of chronic pain based on the premise that the endocannabinoid system signals desensitize pain sensor neurons and produce anti-inflammatory effects. |
2022-01-26 |
2023-08-13 |
Not clear |
| Stephanie E Reitsma, Hari Hara Sudhan Lakshmanan, Jennifer Johnson, Jiaqing Pang, Ivan Parra-Izquierdo, Alex R Melrose, Jaewoo Choi, Deirdre E J Anderson, Monica T Hinds, Jan Frederik Stevens, Joseph E Aslan, Owen J T McCarty, Jamie O L. Chronic edible dosing of Δ9-tetrahydrocannabinol (THC) in non-human primates reduces systemic platelet activity and function. American journal of physiology. Cell physiology. 2022-01-26. PMID:35080922. |
the major psychoactive ingredient of cannabis is Δ9-tetrahydrocannabinol (thc) that signals mainly through cannabinoid receptor-1 (cbr), which is also present on non-neuron cells including blood platelets of the circulatory system. |
2022-01-26 |
2023-08-13 |
Not clear |
| Yuki Sugaya, Masanobu Kan. Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures. Frontiers in neural circuits. vol 15. 2022-01-20. PMID:35046779. |
furthermore, recent endocannabinoid research has paved the way for the clinical use of cannabidiol for the treatment of refractory epilepsy, such as dravet syndrome, lennox-gastaut syndrome and tuberous sclerosis complex. |
2022-01-20 |
2023-08-13 |
Not clear |